Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,115,878
-
Share change
-
+3,552
-
Total reported value
-
$962,855,725
-
Put/Call ratio
-
36%
-
Price per share
-
$31.97
-
Number of holders
-
112
-
Value change
-
+$1,243,940
-
Number of buys
-
48
-
Number of sells
-
44
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q4 2014
As of 31 Dec 2014,
GENOMIC HEALTH INC - COM (GHDX) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,115,878 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Camber Capital Management LLC, BAILLIE GIFFORD & CO, NORTH TIDE CAPITAL, LLC, Champlain Investment Partners, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, and MILLENNIUM MANAGEMENT LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.